Soligenix, Inc. (SNGX)
$0.33-5.71%Close
SELLCRISIS · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $5M
- Beta
- 2.00
- P/E (TTM)
- -0.26
- Short % float
- 1.14%
- Days to cover
- 1.0
- SI change
- -17.0%
- 1W
- -8.33%
- 1M
- -8.33%
- vs SPY 1W
- -8.19%
- vs SPY 1M
- -10.84%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on SNGX?
- LOPJLB’s latest quantitative signal on Soligenix, Inc. (SNGX) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is SNGX in?
- Soligenix, Inc. (SNGX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Soligenix, Inc. (SNGX) do?
- Soligenix, Inc., a biopharmaceutical firm in its advanced development stages, concentrates on bringing innovative products to market within the United States, specifically targeting rare illnesses. The company's operations are divided into two main divisions: Specialized BioTherapeutics and Public Health Solutions. Within the Specialized BioTherapeutics division, Soligenix is advancing SGX301 (…